Adherence to risk evaluation and mitigation strategies (REMS) requirements for monthly testing of liver function
Background: Risk evaluation and mitigation strategies (REMS), as mandated by the US Food and Drug Administration (FDA) for medications with the potential for harm, are increasingly incorporating rigid protocols for patient evaluation, but little is known about compliance with these programs. Despite...
Main Authors: | Christopher M Blanchette, Anthony P Nunes, Nancy D Lin, Kathleen M Mortimer, Joshua Noone, Krishna Tangirala, Stephen Johnston, Benjamin Gutierrez |
---|---|
Format: | Article |
Language: | English |
Published: |
BioExcel Publishing Ltd
2015-02-01
|
Series: | Drugs in Context |
Subjects: | |
Online Access: | http://www.drugsincontext.com/adherence-to-risk-evaluation-and-mitigation-strategies-rems-requirements-for-monthly-testing-of-liver-function/ |
Similar Items
-
Burden of proof for the illegal immissions as prerequisite of in rem removal claim
by: Knežević Marko
Published: (2013-01-01) -
An upper and lower bound of the Medication Possession Ratio
by: Sperber CM, et al.
Published: (2017-08-01) -
Optimization of REMS Program Compliance in a Large Academic Health System
by: Audrey B Kostrzewa
Published: (2021-05-01) -
Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide
by: Chow W, et al.
Published: (2020-11-01) -
Pragmatic applications of implementation science frameworks to regulatory science: an assessment of FDA Risk Evaluation and Mitigation Strategies (REMS) (2014–2018)
by: Linda Huynh, et al.
Published: (2021-08-01)